SCHEMBL11028148

SCHEMBL11028148

CCCCCCCCCCCCCC=Cc1ccc(C(=O)O)c(C)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 1/20 0.51
TNNC1 P63316 1/20 0.45
PPARA Q07869 3/20 0.43
TRPM2 O94759 1/20 0.41
PDE5A O76074 1/20 0.41
ALDH1A1 P00352 4/20 0.41
F7 P08709 3/20 0.41
F3 P13726 3/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
DUSP3 P51452 1/20 0.41
PTPN7 P35236 1/20 0.41
KDM4E B2RXH2 1/20 0.41
FFAR1 O14842 1/20 0.41
LMNA P02545 1/20 0.41
FABP3 P05413 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP19A1 P11511 1/20 0.41
FABP4 P15090 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11028146 1.00 RARB (0.51) RARBTNNC1PPARATRPM2PDE5A
SCHEMBL10635749 0.94 RARB (0.47) RARBTNNC1PPARATRPM2PDE5A
SCHEMBL20556305 0.88 RARB (0.43) RARBTRPM2ALDH1A1KDM4ETDP1
SCHEMBL20556511 0.88 RARB (0.43) RARBTRPM2ALDH1A1KDM4ETDP1
SCHEMBL20556303 0.88 RARB (0.43) RARBTRPM2ALDH1A1KDM4ETDP1
SCHEMBL6437412 0.84 F7 (0.41) TNNC1PPARATRPM2PDE5AALDH1A1
SCHEMBL10728796 0.83 PTPN1 (0.58) F7F3KDM4EALOX15HSD17B10
SCHEMBL10728792 0.83 PTPN1 (0.58) F7F3KDM4EALOX15HSD17B10
SCHEMBL11026071 0.82 HDAC1 (0.43) RARBTNNC1PPARATRPM2PDE5A
SCHEMBL11026068 0.82 HDAC1 (0.43) RARBTNNC1PPARATRPM2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673882-B2 Inhibitors of autotaxin UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2014-03-18 US disclosed
US-20120190650-A1 Inhibitors of Autotaxin UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190650-A1 Inhibitors of Autotaxin ENPP2, PHPT1, PSPH RARB 3143/4885TNNC1 968/4885PPARA 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.